Nuclear Medicine Radioisotopes Market Size, Share, Growth, and Industry Analysis, By Type (Thallium-201 (Tl-201),Iodine (I-123),Fluorine-18,Rubidium-82 (Rb-82),Other), By Application (Tumor,Heart Disease,Lymphoma,Thyroid Gland,Other), Regional Insights and Forecast to 2033

Detailed TOC of Global and United States Nuclear Medicine Radioisotopes Market Report & Forecast 2022-2028

1 Study Coverage
1.1 Nuclear Medicine Radioisotopes Product Introduction
1.2 Global Nuclear Medicine Radioisotopes Outlook 2017 VS 2022 VS 2028
1.2.1 Global Nuclear Medicine Radioisotopes Sales in US$ Million for the Year 2017-2028
1.2.2 Global Nuclear Medicine Radioisotopes Sales in Volume for the Year 2017-2028
1.3 United States Nuclear Medicine Radioisotopes Outlook 2017 VS 2022 VS 2028
1.3.1 United States Nuclear Medicine Radioisotopes Sales in US$ Million for the Year 2017-2028
1.3.2 United States Nuclear Medicine Radioisotopes Sales in Volume for the Year 2017-2028
1.4 Nuclear Medicine Radioisotopes Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Nuclear Medicine Radioisotopes in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Nuclear Medicine Radioisotopes Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Nuclear Medicine Radioisotopes Market Dynamics
1.5.1 Nuclear Medicine Radioisotopes Industry Trends
1.5.2 Nuclear Medicine Radioisotopes Market Drivers
1.5.3 Nuclear Medicine Radioisotopes Market Challenges
1.5.4 Nuclear Medicine Radioisotopes Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Nuclear Medicine Radioisotopes Market Segment by Type
2.1.1 Thallium-201 (Tl-201)
2.1.2 Iodine (I-123)
2.1.3 Fluorine-18
2.1.4 Rubidium-82 (Rb-82)
2.1.5 Other
2.2 Global Nuclear Medicine Radioisotopes Market Size by Type
2.2.1 Global Nuclear Medicine Radioisotopes Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Nuclear Medicine Radioisotopes Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Nuclear Medicine Radioisotopes Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Nuclear Medicine Radioisotopes Market Size by Type
2.3.1 United States Nuclear Medicine Radioisotopes Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Nuclear Medicine Radioisotopes Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Nuclear Medicine Radioisotopes Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Nuclear Medicine Radioisotopes Market Segment by Application
3.1.1 Tumor
3.1.2 Heart Disease
3.1.3 Lymphoma
3.1.4 Thyroid Gland
3.1.5 Other
3.2 Global Nuclear Medicine Radioisotopes Market Size by Application
3.2.1 Global Nuclear Medicine Radioisotopes Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Nuclear Medicine Radioisotopes Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Nuclear Medicine Radioisotopes Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Nuclear Medicine Radioisotopes Market Size by Application
3.3.1 United States Nuclear Medicine Radioisotopes Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Nuclear Medicine Radioisotopes Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Nuclear Medicine Radioisotopes Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Nuclear Medicine Radioisotopes Competitor Landscape by Company
4.1 Global Nuclear Medicine Radioisotopes Market Size by Company
4.1.1 Top Global Nuclear Medicine Radioisotopes Manufacturers Ranked by Revenue (2021)
4.1.2 Global Nuclear Medicine Radioisotopes Revenue by Manufacturer (2017-2022)
4.1.3 Global Nuclear Medicine Radioisotopes Sales by Manufacturer (2017-2022)
4.1.4 Global Nuclear Medicine Radioisotopes Price by Manufacturer (2017-2022)
4.2 Global Nuclear Medicine Radioisotopes Concentration Ratio (CR)
4.2.1 Nuclear Medicine Radioisotopes Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Nuclear Medicine Radioisotopes in 2021
4.2.3 Global Nuclear Medicine Radioisotopes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Nuclear Medicine Radioisotopes Manufacturing Base Distribution, Product Type
4.3.1 Global Nuclear Medicine Radioisotopes Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Nuclear Medicine Radioisotopes Product Type
4.3.3 Date of International Manufacturers Enter into Nuclear Medicine Radioisotopes Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Nuclear Medicine Radioisotopes Market Size by Company
4.5.1 Top Nuclear Medicine Radioisotopes Players in United States, Ranked by Revenue (2021)
4.5.2 United States Nuclear Medicine Radioisotopes Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Nuclear Medicine Radioisotopes Sales by Players (2020, 2021 & 2022)
5 Global Nuclear Medicine Radioisotopes Market Size by Region
5.1 Global Nuclear Medicine Radioisotopes Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Nuclear Medicine Radioisotopes Market Size in Volume by Region (2017-2028)
5.2.1 Global Nuclear Medicine Radioisotopes Sales in Volume by Region: 2017-2022
5.2.2 Global Nuclear Medicine Radioisotopes Sales in Volume Forecast by Region (2023-2028)
5.3 Global Nuclear Medicine Radioisotopes Market Size in Value by Region (2017-2028)
5.3.1 Global Nuclear Medicine Radioisotopes Sales in Value by Region: 2017-2022
5.3.2 Global Nuclear Medicine Radioisotopes Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Nuclear Medicine Radioisotopes Market Size YoY Growth 2017-2028
6.1.2 North America Nuclear Medicine Radioisotopes Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Nuclear Medicine Radioisotopes Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Nuclear Medicine Radioisotopes Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Nuclear Medicine Radioisotopes Market Size YoY Growth 2017-2028
6.3.2 Europe Nuclear Medicine Radioisotopes Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Nuclear Medicine Radioisotopes Market Size YoY Growth 2017-2028
6.4.2 Latin America Nuclear Medicine Radioisotopes Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Nuclear Medicine Radioisotopes Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Nuclear Medicine Radioisotopes Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Agfa-Gevaert Group
7.1.1 Agfa-Gevaert Group Corporation Information
7.1.2 Agfa-Gevaert Group Description and Business Overview
7.1.3 Agfa-Gevaert Group Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Agfa-Gevaert Group Nuclear Medicine Radioisotopes Products Offered
7.1.5 Agfa-Gevaert Group Recent Development
7.2 Braco
7.2.1 Braco Corporation Information
7.2.2 Braco Description and Business Overview
7.2.3 Braco Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Braco Nuclear Medicine Radioisotopes Products Offered
7.2.5 Braco Recent Development
7.3 Cardiarc
7.3.1 Cardiarc Corporation Information
7.3.2 Cardiarc Description and Business Overview
7.3.3 Cardiarc Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Cardiarc Nuclear Medicine Radioisotopes Products Offered
7.3.5 Cardiarc Recent Development
7.4 Cardinal Health
7.4.1 Cardinal Health Corporation Information
7.4.2 Cardinal Health Description and Business Overview
7.4.3 Cardinal Health Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Cardinal Health Nuclear Medicine Radioisotopes Products Offered
7.4.5 Cardinal Health Recent Development
7.5 CMR Naviscan (Gamma Medica Inc.)
7.5.1 CMR Naviscan (Gamma Medica Inc.) Corporation Information
7.5.2 CMR Naviscan (Gamma Medica Inc.) Description and Business Overview
7.5.3 CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2017-2022)
7.5.4 CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Products Offered
7.5.5 CMR Naviscan (Gamma Medica Inc.) Recent Development
7.6 Curium
7.6.1 Curium Corporation Information
7.6.2 Curium Description and Business Overview
7.6.3 Curium Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Curium Nuclear Medicine Radioisotopes Products Offered
7.6.5 Curium Recent Development
7.7 Digirad
7.7.1 Digirad Corporation Information
7.7.2 Digirad Description and Business Overview
7.7.3 Digirad Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Digirad Nuclear Medicine Radioisotopes Products Offered
7.7.5 Digirad Recent Development
7.8 GE Healthcare
7.8.1 GE Healthcare Corporation Information
7.8.2 GE Healthcare Description and Business Overview
7.8.3 GE Healthcare Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2017-2022)
7.8.4 GE Healthcare Nuclear Medicine Radioisotopes Products Offered
7.8.5 GE Healthcare Recent Development
7.9 Nordion (Canada)
7.9.1 Nordion (Canada) Corporation Information
7.9.2 Nordion (Canada) Description and Business Overview
7.9.3 Nordion (Canada) Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Nordion (Canada) Nuclear Medicine Radioisotopes Products Offered
7.9.5 Nordion (Canada) Recent Development
7.10 NTP Radioisotopes SOC
7.10.1 NTP Radioisotopes SOC Corporation Information
7.10.2 NTP Radioisotopes SOC Description and Business Overview
7.10.3 NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2017-2022)
7.10.4 NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Products Offered
7.10.5 NTP Radioisotopes SOC Recent Development
7.11 Positron
7.11.1 Positron Corporation Information
7.11.2 Positron Description and Business Overview
7.11.3 Positron Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Positron Nuclear Medicine Radioisotopes Products Offered
7.11.5 Positron Recent Development
7.12 Segami
7.12.1 Segami Corporation Information
7.12.2 Segami Description and Business Overview
7.12.3 Segami Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Segami Products Offered
7.12.5 Segami Recent Development
7.13 Siemens Healthcare
7.13.1 Siemens Healthcare Corporation Information
7.13.2 Siemens Healthcare Description and Business Overview
7.13.3 Siemens Healthcare Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Siemens Healthcare Products Offered
7.13.5 Siemens Healthcare Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Nuclear Medicine Radioisotopes Industry Chain Analysis
8.2 Nuclear Medicine Radioisotopes Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Nuclear Medicine Radioisotopes Distributors
8.3 Nuclear Medicine Radioisotopes Production Mode & Process
8.4 Nuclear Medicine Radioisotopes Sales and Marketing
8.4.1 Nuclear Medicine Radioisotopes Sales Channels
8.4.2 Nuclear Medicine Radioisotopes Distributors
8.5 Nuclear Medicine Radioisotopes Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer